EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sigma-1 Receptor Stimulation Rescues FTD/ALS Mutant TDP43-Induced Disruption of the VAPB-PTPIP51 ER–Mitochondria Tethering Proteins via Inhibition of GSK3β

Kerry Blair iD, Philippe Gosset iD, Raquel Martinez-Serra, Gábor M Mórotz iD, Sandra M Martín-Guerrero iD, Patricia Gomez-Suaga iD, Joseph Atherton iD, Jacqueline C Mitchell iD, Wendy Noble, Christopher C J Miller, Andrea Markovinovic iD

Cells · 2026

DOI: 10.3390/cells15171536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Kerry Blair und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London WC2R 2LS, UK. Hauptthemen laut MEDLINE: Receptors, sigma, Glycogen Synthase Kinase 3 beta, DNA-Binding Proteins, Endoplasmic Reticulum. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer's Research UK, Medical Research Council, Alzheimer's Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Signalling between the ER and mitochondria regulates a number of key cellular functions that are damaged in frontotemporal dementia and related amyotrophic lateral sclerosis (FTD/ALS). This signalling involves close physical contacts between the two organelles that are mediated by the VAPB-PTPIP51 ER–mitochondria “tethering” proteins. A number of studies have shown that mutant genes which cause familial FTD/ALS disrupt the VAPB-PTPIP51 tethers and that this involves activation of GSK3β. TDP43 is one such mutant and altered TDP43 metabolism is central to FTD/ALS pathogenesis. Loss of Sigma-1 receptor function is also seen in FTD/ALS and there is evidence that Sigma-1 receptor agonists can repair damaged ER–mitochondria signalling. However, the underlying mechanisms are not properly understood. In this study, we show that the reference Sigma-1 receptor agonist PRE-084 stimulates VAPB-PTPIP51 binding and rescues FTD/ALS mutant TDP43-induced disruption to the VAPB-PTPIP51 interaction and linked ER–mitochondria Ca2+ delivery. We also show that these effects involve inhibition of the kinase GSK3β, a known negative regulator of VAPB-PTPIP51 binding. Finally, we show that ANAVEX2-73, a further Sigma-1 receptor agonist which is in clinical trials for Alzheimer’s disease, also stimulates VAPB-PTPIP51 binding via GSK3β inhibition. Our findings provide novel insights into the mechanisms by which Sigma-1 receptor agonists influence defective ER–mitochondria signalling in FTD/ALS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, sigmaGlycogen Synthase Kinase 3 betaDNA-Binding ProteinsEndoplasmic ReticulumMitochondriaAmyotrophic Lateral SclerosisMutationFrontotemporal DementiaMitochondrial ProteinsSigma-1 ReceptorHumansAnimalsProtein BindingMitochondria Associated MembranesCalcium

Stichwörter der Autor:innen

ANAVEX2-73PRE-084PTPIP51Sigma-1 receptorTDP43VAPBamyotrophic lateral sclerosisfrontotemporal dementia

Substanzen

Receptors, sigmaSigma-1 ReceptorGlycogen Synthase Kinase 3 betaDNA-Binding ProteinsMitochondrial ProteinsGSK3B protein, humanTARDBP protein, humanCalcium

Autor:innen und Institutionen

  • Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London WC2R 2LS, UK.
  • Randall Centre for Cell and Molecular Biophysics, King's College London, London WC2R 2LS, UK.
  • Department of Pharmacology and Pharmacotherapy, Semmelweis University, H-1089 Budapest, Hungary.
  • Center for Pharmacology and Drug Research & Development, Semmelweis University, H-1085 Budapest, Hungary.
  • Consejo Superior de Investigaciones Científicas (CSIC), Instituto de Parasitología y Biomedicina López-Neyra, 18016 Granada, Spain.
  • Departamento de Bioquímica y Biología Molecular y Genética, Facultad de Enfermería y Terapia Ocupacional, Universidad de Extremadura, 10071 Cáceres, Spain.

ORCID-Profile: Kerry Blair, Philippe Gosset, Gábor M Mórotz, Sandra M Martín-Guerrero, Patricia Gomez-Suaga, Joseph Atherton, Jacqueline C Mitchell, Andrea Markovinovic

Förderung

  • Alzheimer's Research UK
  • Medical Research Council
  • Alzheimer's Society
  • Alzheimer’s Research UK
  • UKRI-MRC
  • Alzheimer’s Society
  • UK Motor Neurone Disease Association
  • ICGEB

Zitieren

APA

Blair, K., Gosset, P., Martinez-Serra, R., Mórotz, G. M., Martín-Guerrero, S. M., Gomez-Suaga, P., Atherton, J., Mitchell, J. C., Noble, W., Miller, C. C. J., & Markovinovic, A. (2026). Sigma-1 Receptor Stimulation Rescues FTD/ALS Mutant TDP43-Induced Disruption of the VAPB-PTPIP51 ER–Mitochondria Tethering Proteins via Inhibition of GSK3β. Cells. https://doi.org/10.3390/cells15171536

Vancouver

Blair K, Gosset P, Martinez-Serra R, Mórotz GM, Martín-Guerrero SM, Gomez-Suaga P, et al. Sigma-1 Receptor Stimulation Rescues FTD/ALS Mutant TDP43-Induced Disruption of the VAPB-PTPIP51 ER–Mitochondria Tethering Proteins via Inhibition of GSK3β. Cells. 2026. doi:10.3390/cells15171536

BibTeX
@article{Blair2026,
  author = {Blair, Kerry and Gosset, Philippe and Martinez-Serra, Raquel and Mórotz, Gábor M and Martín-Guerrero, Sandra M and Gomez-Suaga, Patricia and Atherton, Joseph and Mitchell, Jacqueline C and Noble, Wendy and Miller, Christopher C J and Markovinovic, Andrea},
  title = {Sigma-1 Receptor Stimulation Rescues FTD/ALS Mutant TDP43-Induced Disruption of the VAPB-PTPIP51 ER–Mitochondria Tethering Proteins via Inhibition of GSK3β},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15171536}
}
Kostenlos starten →